Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will report its financial results for the fourth quarter and full year 2012 on Wednesday, March 6, 2013 after market close. The announcement will be followed by a conference call with the investment community, on Thursday, March 7, 2013, at 8:30 a.m. EST to provide a business update and discuss its financial and operational results.